Abstract Body

We have recently identified the multipass transmembrane proteins SERINC3 and SERINC5 as novel antiviral proteins that restrict HIV-1 infectivity. Nef enhances HIV infectivity by removing SERINCs from the plasma membrane, which prevents their incorporation into progeny HIV-1 virions. However, the determinants that govern the sensitivity of SERINCs to Nef remain unknown.

We examined the inhibitory function of widely divergent SERINC5 proteins from different vertebrate species. To identify determinants responsible for the responsiveness of SERINC5 to Nef, we generated chimeras between Nef-sensitive and Nef-resistant SERINCs. We examined their ability to inhibit HIV-1 infectivity, their incorporation into HIV-1 virions, and their cell surface expression in the absence or presence of Nef.

We find that the ability to inhibit HIV-1 infectivity is conserved among vertebrate SERINC5 proteins, whereas the sensitivity to downregulation by Nef is not. For instance, human and frog SERINC5 inhibited HIV-1 infectivity with similar potency, but frog SERINC5 was resistant to HIV-1 Nefs from different clades. Furthermore, our results indicate that sensitivity to Nef is, at least in part, governed by the fourth intracellular loop of SERINC5. A Nef-resistant SERINC5 became Nef-sensitive when intracellular loop 4 was replaced by that of human SERINC5. Conversely, human SERINC5 became resistant to Nef when its intracellular loop 4 was replaced by that of a Nef-resistant SERINC protein. We previously showed that HIV-1 SF2 Nef selectively inhibits the incorporation of SERINC5 but not of SERINC3 into progeny virions. Thus, we replaced the fourth internal loop of human SERINC3 by that of human SERINC5, and found that HIV-1 SF2 Nef strongly inhibited the incorporation of the resulting chimera into HIV-1 virions. In general, the fourth intracellular loop from SERINCs that exhibited resistance to a given Nef conferred resistance to the same Nef when transferred to a sensitive SERINC, and vice versa.

Taken together, our results identify a major determinant of Nef responsiveness, and establish that human SERINC5 can be made to restrict HIV-1 infectivity even in the presence of Nef.